Transcriptomic and proteomic profiling revealed reprogramming of carbon metabolism in acetate-grown human pathogen Candida glabrata

Abstract

Background Emergence of Candida glabrata, which causes potential life-threatening invasive candidiasis, has been widely associated with high morbidity and mortality. In order to cause disease in vivo, a robust and highly efficient metabolic adaptation is crucial for the survival of this fungal pathogen in human host. In fact, reprogramming of the carbon metabolism is believed to be indispensable for phagocytosed C. glabrata within glucose deprivation condition during infection. Methods In this study, the metabolic responses of C. glabrata under acetate growth condition was explored using high-throughput transcriptomic and proteomic approaches. Results Collectively, a total of 1482 transcripts (26.96%) and 242 proteins (24.69%) were significantly up- or down-regulated. Both transcriptome and proteome data revealed that the regulation of alternative carbon metabolism in C. glabrata resembled other fungal pathogens such as Candida albicans and Cryptococcus neoformans, with up-regulation of many proteins and transcripts from the glyoxylate cycle and gluconeogenesis, namely isocitrate lyase (ICL1), malate synthase (MLS1), phosphoenolpyruvate carboxykinase (PCK1) and fructose 1,6-biphosphatase (FBP1). In the absence of glucose, C. glabrata shifted its metabolism from glucose catabolism to anabolism of glucose intermediates from the available carbon source. This observation essentially suggests that the glyoxylate cycle and gluconeogenesis are potentially critical for the survival of phagocytosed C. glabrata within the glucose-deficient macrophages. Conclusion Here, we presented the first global metabolic responses of C. glabrata to alternative carbon source using transcriptomic and proteomic approaches. These findings implicated that reprogramming of the alternative carbon metabolism during glucose deprivation could enhance the survival and persistence of C. glabrata within the host.

Integrative transcriptome and proteome revealed high-yielding mechanisms of epsilon-poly-L-lysine by Streptomyces albulus

“…These results indicated that WG-608 had considerably greater capability for essential amino acid biosynthesis. Consistent with our results, Wang Z. Y. et al (2021) and also found that the synthesis of amino acids (i.e., L-lysine, L-threonine and L-proline) was upregulated in the high ε-PL-producing strain Streptomyces diastatochromogenes 6#-7 . Additionally, other studies have shown that L-arginine levels contribute to the arginine deaminase pathway to enhance acid resistance, while high L-glutamate and L-proline levels promote cellular tolerance and acclimation to environmental extremes.…”

The impact of COVID-19 on the male reproductive tract and fertility: A systematic review

“…SARS-CoV-2 gains access to cells via ACE2 receptor binding with TMPRSS2 priming [ 7 , 8 ]. The testes are reported to express ACE2, particularly in the spermatogonia, Leydig cells and Sertoli cells, which leads to the hypothesis of SARS-CoV-2 gaining access to testicular tissues and seminal fluid, directly affecting male reproductive health [ 58 ].…”

“…The SARS-CoV-2 virus gains access to human cells through binding to cellular angiotensin-converting enzyme 2 (ACE2) receptors via the receptor-binding domain as part of the spike (S) protein. This further requires priming by cellular transmembrane protease, serine 2 (TMPRSS2) [ 7 , 8 ]. Following infection through exposure to respiratory droplets, the incubation period is usually 3–7 days [ 8 ].…”

“…The first phase is characterised by increased viral transmission rates and replication, particularly through the respiratory tract due to the high expression of ACE2 and TMPRSS2. Phase 2 is a host-specific (including gender- and age-specific) characterised by a hyperinflammatory response, hypercytokinaemia and collateral tissue damage that may result in acute respiratory distress and systemic failure [ 7 , 8 ]. Increased risk for phase 2 complications includes older age, obesity, hypertension, diabetes and chronic respiratory disease [ 12 ].…”

Overcoming Multidrug Resistance in Bacteria Through Antibiotics Delivery in Surface-Engineered Nano-Cargos: Recent Developments for Future Nano-Antibiotics

“…The use of antibiotic-loaded nano-formulations is considered a valid strategy for bacteria targeting because of its numerous advantages over conventional formulations, including improved stability, controlled antibiotic release, targeted capability, and increased bioavailability (Pant et al, 2021 ). Some issues, such as solubility, drug resistance, and epithelium permeation, can also be resolved by targeting pathogens of nanocarriers.…”